PDS Biotechnology Signs Cooperative Research and Development Agreement with National Cancer Institute to Perform a Phase 2 Clinical Study of PDS0101 in Combination with Other Immune-modulating Agents in Advanced HPV-related Cancers

Frank Burrell
Scientific Storytelling

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

David Linetsky
Point-of-Care Marketing

Matt Turner
Patient Affordability

Daniel Sontupe
Market Access

Joey Cohen
Medication Adherence

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach

Pat Purcell
Meeting Engagement

Suma Ramadas, PhD
Medical Affairs

Matthew Durham
Omnidynamic Marketing

Liz Kane
Impactful Strategy

Paul Theisen
Patient Acquisition